Doctor profile · Federal record
Dr. Tatyana Groysman, D.O.
Dermatology Physician (CMS: Dermatology) · Dermatopathology Physician · New York, NY
- NPI 1346477445
- 17 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
150 W 55Th St
New York, NY 100195586
(212) 991-6490 - Mailing address
-
145 E 32Nd St, 10Th Floor
New York, NY 100166055
Credentials & registration
- NPI registered
- June 2009 — 17 yrs on file
- Profile last updated
- March 7, 2025
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #270290
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346477445. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
611
Distinct HCPCS
10
Medicare allowed
$36,467
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 231 | 43 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 107 | 85 | $100 | |
17000 |
Destruction of precancer skin growth, 1 growth | 55 | 49 | $57 | |
11102 |
Biopsy of related skin growth, first growth | 42 | 41 | $105 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 42 | 34 | $140 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 31 | 31 | $128 | |
17110 |
Destruction of skin growth, 1-14 growths | 30 | 20 | $125 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 28 | 18 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 26 | 22 | $62 | |
11901 |
Injection into skin growth, more than 7 growths | 19 | 12 | $65 |
In context: peer comparison
Among 139 peers in New York Dermatology Physician, average services per provider: 182. This provider delivers 3.4× the peer median.Open Payments
Industry payments received
All-time total
$2,096
Transactions
93
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 11 | $500.38 | |
| Abbvie INC. | 25 | $365.35 | |
| Amgen INC. | 8 | $198.24 | |
| Arcutis Biotherapeutics, INC. | 11 | $189.26 | |
| Dermavant Sciences, INC. | 10 | $177.19 | |
| Pfizer INC. | 9 | $149.73 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 2 | $147.13 | |
| Lilly USA, LLC | 3 | $86.26 | |
| Novartis Pharmaceuticals Corporation | 4 | $82.62 | |
| Verrica Pharmaceuticals INC. | 3 | $55.95 | |
| Incyte Corporation | 2 | $48.97 | |
| Leo Pharma INC. | 2 | $45.80 | |
| Ucb, INC. | 2 | $34.86 | |
| Strata Skin Sciences, INC. | 1 | $14.40 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
219
Patients
128
Total drug cost
$23,946
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 57 | 38 | $1,229 |
| Triamcinolone Acetonide | Generic | 39 | 31 | $550 |
| Fluocinonide | Generic | 25 | 17 | $1,540 |
| Mupirocin | Generic | 23 | 18 | $201 |
| Clobetasol Propionate | Generic | 14 | 13 | $748 |
| Jublia (Efinaconazole) | Brand | 14 | 0 | $17,732 |
| Ammonium Lactate | Generic | 12 | 0 | $337 |
| Hydrocortisone | Generic | 12 | 11 | $130 |
| Minoxidil | Generic | 12 | 0 | $182 |
| Metronidazole | Generic | 11 | 0 | $1,297 |
Frequently asked questions
What is Dr. Tatyana Groysman's medical specialty?
Dr. Tatyana Groysman practices Dermatology Physician in New York, NY.
Where does Dr. Tatyana Groysman practice?
Dr. Tatyana Groysman practices at 150 W 55Th St, New York, NY 100195586. Office phone: 2129916490.
What is Dr. Tatyana Groysman's NPI?
Dr. Tatyana Groysman's National Provider Identifier (NPI) is 1346477445, issued by NPPES.
Does Dr. Tatyana Groysman accept Medicare assignment?
Dr. Tatyana Groysman does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Tatyana Groysman commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.